Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate |
2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e421a40bb6560bfd11074ed78df15353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a706926c5c3cb30b022a6c04d4365bda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3b648a3864a9a6c3bcd62696c387d48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7727d2ff227e74b1f9c11afee2491c14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07f287418853fb95bb4b0d1c2fc521cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44990ef5db0b495b56ee278faf47e72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff4a1917571aaea0053b2955f6229dc3 |
publicationDate |
2021-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021130908-A1 |
titleOfInvention |
Tert promoter mutations in urothelial neoplasia |
abstract |
TERT promoter mutations occur in both papillary and flat lesion bladder cancers, are the most frequent genetic alterations identified to date in noninvasive precursor lesions of the bladder, are detectable in urine, and appear to be strongly associated with bladder cancer recurrence. The TERT promoter mutations are useful urinary biomarker for both the early detection and monitoring of bladder neoplasia. |
priorityDate |
2013-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |